My Blog List

Wednesday, 3 January 2018

EMEA (Europe, Middle East and Africa) Point of Care (PoC) Molecular Diagnostics Market and Industry Analysis Report 2018

Description:

In this report, the EMEA Point of Care (PoC) Molecular Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Point of Care (PoC) Molecular Diagnostics for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.


EMEA Point of Care (PoC) Molecular Diagnostics market competition by top manufacturers/players, with Point of Care (PoC) Molecular Diagnostics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies


On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories

For any enquires before buying, connect with us @ https://www.reporthive.com/enquiry.php?id=1246386&req_type=disc

Table of Content:

1 Point of Care (PoC) Molecular Diagnostics Overview1.1 Product Overview and Scope of Point of Care (PoC) Molecular Diagnostics
1.2 Classification of Point of Care (PoC) Molecular Diagnostics
1.2.1 EMEA Point of Care (PoC) Molecular Diagnostics Market Size (Sales) Comparison by Type (2012–2022)
1.2.2 EMEA Point of Care (PoC) Molecular Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Polymerase Chain Reaction (Real Time PCR)
1.2.4 In Situ Hybridization
1.2.5 Chips and Microarrays
1.2.6 Mass Spectrometry
1.2.7 Sequencing
1.2.8 Isothermal Amplification
1.2.9 Others
1.3 EMEA Point of Care (PoC) Molecular Diagnostics Market by Application/End Users
1.3.1 EMEA Point of Care (PoC) Molecular Diagnostics Sales (Volume) and Market Share Comparison by Application (2012–2022
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research & Academic Laboratories
1.4 EMEA Point of Care (PoC) Molecular Diagnostics Market by Region
1.4.1 EMEA Point of Care (PoC) Molecular Diagnostics Market Size (Value) Comparison by Region (2012–2022)
1.4.2 Europe Status and Prospect (2012–2022)
1.4.3 Middle East Status and Prospect (2012–2022)
1.4.4 Africa Status and Prospect (2012–2022)
1.5 EMEA Market Size (Value and Volume) of Point of Care (PoC) Molecular Diagnostics (2012–2022)
1.5.1 EMEA Point of Care (PoC) Molecular Diagnostics Sales and Growth Rate (2012–2022)
1.5.2 EMEA Point of Care (PoC) Molecular Diagnostics Revenue and Growth Rate (2012–2022)

2 EMEA Point of Care (PoC) Molecular Diagnostics Competition by Manufacturers/Players/Suppliers, Region, Type and Application2.1 EMEA Point of Care (PoC) Molecular Diagnostics Market Competition by Players/Manufacturers
2.1.1 EMEA Point of Care (PoC) Molecular Diagnostics Sales Volume and Market Share of Major Players (2012–2017)
2.1.2 EMEA Point of Care (PoC) Molecular Diagnostics Revenue and Share by Players (2012–2017)
2.1.3 EMEA Point of Care (PoC) Molecular Diagnostics Sale Price by Players (2012–2017)
2.2 EMEA Point of Care (PoC) Molecular Diagnostics (Volume and Value) by Type/Product Category
2.2.1 EMEA Point of Care (PoC) Molecular Diagnostics Sales and Market Share by Type (2012–2017)
2.2.2 EMEA Point of Care (PoC) Molecular Diagnostics Revenue and Market Share by Type (2012–2017)
2.2.3 EMEA Point of Care (PoC) Molecular Diagnostics Sale Price by Type (2012–2017)
2.3 EMEA Point of Care (PoC) Molecular Diagnostics (Volume) by Application
2.4 EMEA Point of Care (PoC) Molecular Diagnostics (Volume and Value) by Region
2.4.1 EMEA Point of Care (PoC) Molecular Diagnostics Sales and Market Share by Region (2012–2017)
2.4.2 EMEA Point of Care (PoC) Molecular Diagnostics Revenue and Market Share by Region (2012–2017)
2.4.3 EMEA Point of Care (PoC) Molecular Diagnostics Sales Price by Region (2012–2017)

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India